NCT00003461View on ClinicalTrials.gov

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 1998

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions
Brain and Central Nervous System TumorsMetastatic CancerNeuroblastoma
Interventions
PROCEDURE

surgical procedure

RADIATION

astatine At 211 monoclonal antibody 81C6

Trial Locations (1)

27710

Duke Comprehensive Cancer Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER

NCT00003461 - Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors | Biotech Hunter | Biotech Hunter